Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases-Reference-Cited by-同舟云学术

Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases

Published:2022-04 Issue: Volume:57 Page:151882
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Yang Li,Zhang Hongjuan^ORCID,Zhang Xiaohui,Tang Yongqiang,Wu Zhigang,Wang Yingmei,Huang Hai,Fu Xin,Liu Jiayan,Hogendoorn Pancras C.W.^ORCID,Cheng Hong^ORCID

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference40 articles.

1. CD33+ CD14- phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumor of bone;Forsyth;J Bone Miner Res,2009

2. WHO Classification of Tumours of Soft Tissue and Bone. Giant Cell Tumour of Bone;Athanasou,2013

3. The immunophenotype of osteoclasts and macrophage polykaryons;Maggiani;J Clin Pathol,2011

4. Cell biology of Giant cell tumour of bone: crosstalk between m/wt nucleosome H3.3, telomeres and osteoclastogenesis;Forsyth;Cancers (Basel),2021

5. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study;Chawla;Lancet Oncol,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the mystery: A comprehensive review of multidisciplinary strategies for managing giant cell tumor of the bone;Journal of Orthopaedic Reports;2025-03

2. Experience in Treating a Patient with a Giant Cell Tumor of Complex Localization;Ural Medical Journal;2024-09-03

3. Histones and their practical application in bone tumors: Do I always need them?;Human Pathology;2024-05

4. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update;Current Oncology;2024-04-08

5. Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal;Journal of Bone Oncology;2024-04